Clinical Trial: Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Phase III, Randomised, Double-blind, Stratified Comparative, Placebo Controlled, Parallel Group, Multi-centre Study to Assess the Effect of Deep Subcutaneous Injections of Lanreotide Autogel 120mg Adm

Brief Summary: The study will compare the difference between lanreotide Autogel and placebo on progression free survival in patients who have an endocrine tumour in the pancreas or intestines.